Brian Sosa-Alvarado

Brian Sosa-Alvarado has held various roles in the scientific field since 2008. Brian began as a Graduate Student and Postdoctoral Associate at the Massachusetts Institute of Technology (MIT). In 2014, they became a Postdoctoral Fellow at NYU Langone Medical Center. In 2016, they were a Scientist I at Biogen and Scientist II and Scientist I at Morphic Therapeutic. From 2018 to 2020, they were a Principal Scientist, Associate Principal Scientist, and Senior Scientist at KSQ Therapeutics, Inc. Brian was also a Consultant at Third Rock Ventures and a Director at MOMA Therapeutics in 2020.

Brian Sosa-Alvarado obtained their B.S. in Biology from the Universidad de Puerto Rico in 2008, and their Ph.D. in Biology from the Massachusetts Institute of Technology in 2013.